Alles over het coronavirus (COVID-19) en ALS, PSMA en PLS

Publicaties 2014

Laatst bijgewerkt op 18 januari 2021

In 2014 werden de volgende artikelen gepubliceerd in toonaangevende internationale wetenschappelijke tijdschriften.

Steeds meer wetenschappelijke tijdschriften zijn ‘open acces’. Dat betekent dat er geen abonnementsgelden nodig zijn om artikelen te kunnen lezen. Van deze tijdschriften kunt u via www.pubmed.com het volledige artikel lezen. Pubmed is de database van alle medische publicaties wereldwijd. Van alle andere artikelen staat op Pubmed de Engelstalige samenvatting (abstract). U kunt ook full-text artikelen vinden via de profielen van onze onderzoekers op Researchgate. Bekijk bijvoorbeeld de profielen van dr. Michael van Es en prof. Jeroen Pasterkamp.

Is een artikel full-text niet beschikbaar? Mail naar info@als-centrum.nl voor de pdf.

UMC Utrecht

  1. Goedee SH, Brekelmans GJ, van den Berg LH, Visser LH. Distinctive patterns of sonographic nerve enlargement in Charcot-Marie-Tooth type 1A and hereditary neuropathy with pressure palsies. Clin Neurophysiol 2014;Oct [Epub ahead of print]
  2. Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness. Neurology 2014;83:2124-32.
  3. Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, Scotter EL, Kost J, Keagle P, Miller JW, Calini D, Vance C, Danielson EW, Troakes C, Tiloca C, Al-Sarraj S, Lewis EA, King A, Colombrita C, Pensato V, Castellotti B, de Belleroche J, Baas F, ten Asbroek AL, Sapp PC, McKenna-Yasek D, McLaughlin RL, Polak M, Asress S, Esteban-Pérez J, Muñoz-Blanco JL, Simpson M; SLAGEN Consortium, van Rheenen W, Diekstra FP, Lauria G, Duga S, Corti S, Cereda C, Corrado L, Sorarù G, Morrison KE, Williams KL, Nicholson GA, Blair IP, Dion PA, Leblond CS, Rouleau GA, Hardiman O, Veldink JH, van den Berg LH, Al-Chalabi A, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, García-Redondo A, Wu Z, Glass JD, Gellera C, Ratti A, Brown RH Jr, Silani V, Shaw CE, Landers JE. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 2014;84:324-31.
  4. Van Rheenen W, Diekstra FP, van den Berg LH, Veldink JH. Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis? Brain 2014;137:e313.
  5. Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 2014;13:1108-13.
  6. Van den Berg LH. Therapy of amyotrophic lateral sclerosis remains a challenge. Lancet Neurol 2014;13:1062-3.
  7. Seelen M, Vermeulen RC, van Dillen LS, van der Kooi AJ, Huss A, de Visser M, van den Berg LH, Veldink JH. Residential exposure to extremely low frequency electromagnetic fields and the risk of ALS. Neurology 2014;83:1767-9
  8. Bozik ME, Mitsumoto H, Brooks BR, Rudnicki SA, Moore DH, Zhang B, Ludolph A, Cudkowicz ME, van den Berg LH, Mather J, Petzinger T Jr, Archibald D. A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotroph Lateral Scler Frontotemporal Degener 201415:406-13
  9. Wadman RI, van Bruggen HW, Witkamp TD, Sparreboom-Kalaykova SI, Stam M, van den Berg LH, Steenks MH, van der Pol WL. Bulbar muscle MRI changes in patients with SMA with reduced mouth opening and dysphagia. Neurology 2014;83:1060-6.
  10. Raaphorst J, van Tol MJ, Groot PF, Altena E, van der Werf YD, Majoie CB, van der Kooi AJ, van den Berg LH, Schmand B, de Visser M, Veltman DJ. Prefrontal involvement related to cognitive impairment in progressive muscular atrophy. Neurology 2014 (9):818-25.
  11. Seelen M, van Doormaal PT, Visser AE, Huisman MH, Roozekrans MH, de Jong SW, van der Kooi AJ, de Visser M, Voermans NC, Veldink JH, van den Berg LH. Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol 2014;261:1949-56.
  12. Maessen M, Veldink JH, Onwuteaka-Philipsen BD, Hendricks HT, Schelhaas HJ, Grupstra HF, van der Wal G, van den Berg LH. Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol 2014;261:1894-901.
  13. Genome of the Netherlands Consortium. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet 2014;46:818-25.
  14. Diekstra FP, Van Deerlin VM, van Swieten JC, Al-Chalabi A, Ludolph AC, Weishaupt JH, Hardiman O, Landers JE, Brown RH Jr, van Es MA, Pasterkamp RJ, Koppers M, Andersen PM, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, van Damme P, Melki J, Meininger V, Shatunov A, Shaw CE, Leigh PN, Shaw PJ, Morrison KE, Fogh I, Chiò A, Traynor BJ, Czell D, Weber M, Heutink P, de Bakker PI, Silani V, Robberecht W, van den Berg LH, Veldink JH. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis. Ann Neurol 2014;76:120-33.
  15. Deelen P, Menelaou A, van Leeuwen EM, Kanterakis A, van Dijk F, Medina-Gomez C, Francioli LC, Hottenga JJ, Karssen LC, Estrada K, Kreiner-Møller E, Rivadeneira F, van Setten J, Gutierrez-Achury J, Westra HJ, Franke L, van Enckevort D, Dijkstra M, Byelas H, van Duijn CM; Genome of Netherlands Consortium, de Bakker PI, Wijmenga C, Swertz MA. Improved imputation quality of low-frequency and rare variants in European samples using the ‘Genome of The Netherlands’. Eur J Hum Genet 2014;22:1321-6.
  16. Van Es MA, Veldink JH, Schelhaas HJ, Bloem BR, Sodaar P, van Nuenen BF, Verbeek M, van de Warrenburg BP, van den Berg LH. Serum angiogenin levels are elevated in ALS, but not Parkinson’s disease. Neurol Neurosurg Psychiatry 2014;85:1439-40.
  17. Van Doormaal PT, Ticozzi N, Gellera C, Ratti A, Taroni F, Chiò A, Calvo A, Mora G, Restagno G, Traynor BJ, Birve A, Lemmens R, van Es MA, Saris CG, Blauw HM, van Vught PW, Groen EJ, Corrado L, Mazzini L, Del Bo R, Corti S, Waibel S, Meyer T, Ludolph AC, Goris A, van Damme P, Robberecht W, Shatunov A, Fogh I, Andersen PM, D’Alfonso S, Hardiman O, Cronin S, Rujescu D, Al-Chalabi A, Landers JE, Silani V, van den Berg LH, Veldink JH. Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study. Neurobiol Aging 2014;35:2420.e13-4.
  18. Visser NA, Notermans NC, Degen LA, de Kruijk JR, van den Berg LH, Vrancken AF. Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study. J Peripher Nerv Syst 2014;19:136-44
  19. Harschnitz O, Jongbloed BA, Franssen H, Straver DC, van der Pol WL, van den Berg LH. MMN: From Immunological Cross-Talk to Conduction Block. J Clin Immunol 2014;34 Suppl:S112-9.
  20. Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, Camu W, Neitzel B, Onodera O, van Rheenen W, Pinto S, Weber M, Smith B, Proven M, Talbot K, Keagle P, Chesi A, Ratti A, van der Zee J, Alstermark H, Birve A, Calini D, Nordin A, Tradowsky DC, Just W, Daoud H, Angerbauer S, Dejesus-Hernandez M, Konno T, Lloyd-Jani A, de Carvalho M, Mouzat K, Landers JE, Veldink JH, Silani V, Gitler AD, Shaw CE, Rouleau GA, van den Berg LH, Van Broeckhoven C, Rademakers R, Andersen PM, Kubisch A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. Med Genet 2014;51:419-24.
  21. Seelen M, Visser AE, Overste DJ, Kim HJ, Palud A, Wong TH, van Swieten JC, Scheltens P, Voermans NC, Baas F, de Jong JM, van der Kooi AJ, de Visser M, Veldink JH, Taylor JP, Van Es MA, van den Berg LH. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging 2014;35:1956.e9-1956.e11
  22. Schmidt R, Verstraete E, de Reus MA, Veldink JH, van den Berg LH, van den Heuvel MP. Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:4386-95
  23. Stork AC, Jacobs BC, Tio-Gillen AP, Eurelings M, Jansen MD, van den Berg LH, Notermans NC, van der Pol WL. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol 2014;268:89-94.
  24. Stork AC, Notermans NC, van den Berg LH, Schellevis RD, Niermeijer JM, Nederend M, Leusen JH, van der Pol WL. Fcγ receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry 2014;85:918-20.
  25. Vlam L, Cats EA, Willemse E, Franssen H, Medic J, Piepers S, Veldink JH, van den Berg LH, van der Pol WL. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2014;85:1145-48.
  26. Verstraete E, Polders DL, Mandl RC, Van Den Heuvel MP, Veldink JH, Luijten P, Van Den Berg LH, Hoogduin J. Multimodal tract-based analysis in ALS patients at 7T: a specific white matter profile? Amyotroph Lateral Scler Frontotemporal Degener 2014;15:84-92.
  27. Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, Corrado L, Sorarù G, Cereda C, Corti S, Gentilini D, Calini D, Castellotti B, Mazzini L, Querin G, Gagliardi S, Del Bo R, Conforti FL, Siciliano G, Inghilleri M, Saccà F, Bongioanni P, Penco S, Corbo M, Sorbi S, Filosto M, Ferlini A, Di Blasio AM, Signorini S, Shatunov A, Jones A, Shaw PJ, Morrison KE, Farmer AE, Van Damme P, Robberecht W, Chiò A, Traynor BJ, Sendtner M, Melki J, Meininger V, Hardiman O, Andersen PM, Leigh NP, Glass JD, Overste D, Diekstra FP, Veldink JH, van Es MA, Shaw CE, Weale ME, Lewis CM, Williams J, Brown RH, Landers JE, Ticozzi N, Ceroni M, Pegoraro E, Comi GP, D’Alfonso S, van den Berg LH, Taroni F, Al-Chalabi A, Powell J, Silani V; the SLAGEN Consortium and Collaborators. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2014;23:2220-31
  28. Van Blitterswijk M, Rademakers R, van den Berg LH. Clinical variability and additional mutations in amyotrophic lateral sclerosis patients with p.N352S mutations in TARDBP. Neuropathol Appl Neurobiol 2014;40:356-58.
  29. Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ; The International Multiple Sclerosis Genetics Consortium, van Es M; The Australia and New Zealand MS Genetics Consortium, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH, Shatunov A, Leigh N, Al-Chalabi A, Shaw CE, Traynor BJ, Chiò A, Restagno G, Mora G, Ophoff RA, Oksenberg JR, Van Damme P, Compston A, Robberecht W, Dubois B, van den Berg LH, De Jager PL, Veldink JH, de Bakker PI. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum Mol Genet 2014;23:1916-22.
  30. Van den HeuvelDMA, HarschnitzO, van den BergLH, Pasterkamp Taking a risk: a therapeutic focus on ataxin-2 in ALS? Trends Mol Med 2014;20:25-35.
  31. Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen OP, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G, Walker N, Melle I, Djurovic S, Agartz I, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Olsen L, Hansen T, Ingason A, Pirinen M, Strengman E; GROUP, Hougaard DM, Orntoft T, Didriksen M, Hollegaard MV, Nordentoft M, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Etain B, Bellivier F, Méary A, Schürhoff F, Szoke A, Ribolsi M, Magni V, Siracusano A, Sperling S, Rossner M, Christiansen C, Kiemeney LA, Franke B, van den Berg LH, Veldink J, Curran S, Bolton P, Poot M, Staal W, Rehnstrom K, Kilpinen H, Freitag CM, Meyer J, Magnusson P, Saemundsen E, Martsenkovsky I, Bikshaieva I, Martsenkovska I, Vashchenko O, Raleva M, Paketchieva K, Stefanovski B, Durmishi N, Pejovic Milovancevic M, Lecic Tosevski D, Silagadze T, Naneishvili N, Mikeladze N, Surguladze S, Vincent JB, Farmer A, Mitchell PB, Wright A, Schofield PR, Fullerton JM, Montgomery GW, Martin NG, Rubino IA, van Winkel R, Kenis G, De Hert M, Réthelyi JM, Bitter I, Terenius L, Jönsson EG, Bakker S, van Os J, Jablensky A, Leboyer M, Bramon E, Powell J, Murray R, Corvin A, Gill M, Morris D, O’Neill FA, Kendler K, Riley B; Wellcome Trust Case Control Consortium 2, Craddock N, Owen MJ, O’Donovan MC, Thorsteinsdottir U, Kong A, Ehrenreich H, Carracedo A, Golimbet V, Andreassen OA, Børglum AD, Mors O, Mortensen PB, Werge T, Ophoff RA, Nöthen MM, Rietschel M, Cichon S, Ruggeri M, Tosato S, Palotie A, St Clair D, Rujescu D, Collier DA, Stefansson H, Stefansson K. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry 2014;19:108-14.
  32. Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chiò A, Calvo A, Corbo M, Lunetta C, Marin B, Mitchell D, Hardiman O, Rooney J, Stevic Z, Bandettini di Poggio M, Filosto M, Cotelli MS, Perini M, Riva N, Tremolizzo L, Vitelli E, Damiani D,Beghi E; EURALS Consortium. Physical activity and ALS: a European population-based case-control study. Ann Neurol 2014;75:708-16.

 

AMC

  1. Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A. Prognostic factors for the course of functional status of patients with ALS: a systematic review. J Neurol 2014;Nov 11.
  2. Creemers H, Beelen A, Grupstra H, Nollet F, van den Berg LH. The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: Patients’ perspectives. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:420-5.
  3. Creemers H, Veldink JH, Grupstra H, Nollet F, Beelen A, van den Berg LH. A cluster RCT of case management on patients’ quality of life and caregiver strain in ALS. Neurology 2014;82:23-31.
  4. Raaphorst J, van Tol MJ, Groot PF, Altena E, van der Werf YD, Majoie CB, van der Kooi AJ, van den Berg LH, Schmand B, de Visser M, Veltman DJ. Prefrontal involvement related to cognitive impairment in progressive muscular atrophy. Neurology 2014;83(9):818-25.
  5. Beeldman E, Jaeger B, Raaphorst J, Seelen M, Veldink J, van den Berg L, de Visser M, Schmand B. The verbal fluency index: Dutch normative data for cognitive testing in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014;15(5-6):388-91.
  6. Ranno E, D’Antoni S, Spatuzza M, Berretta A, Laureanti F, Bonaccorso CM, Pellitteri R, Longone P, Spalloni A, Iyer AM, Aronica E, Catania MV. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death. Neurobiol Dis. 2014 May;65:160-71.
  7. Aronica E, Baas F, Iyer A, ten Asbroek AL, Morello G, Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol Dis. 2015 Feb;74:359-76.
Prof. dr. Leonard van den Berg
  • neuroloog en hoogleraar Experimentele Neurologie, UMC Utrecht

Ik ben coördinator van het ALS Centrum en als hoogleraar Experimentele Neurologie verbonden aan het UMC Utrecht. Ik stimuleer internationale samenwerking vanuit mijn voorzitterschap van het ‘European Network to Cure ALS’ (ENCALS) en als coördinator van verschillende Europese onderzoeksprojecten op het gebied van ALS.

Heeft u feedback op dit artikel? Laat het ons weten.